Seòmar agus comataidhean

The Scottish Medicines Consortium (SMC) has not yet received a submission from the manufacturing company, Vertex, for exagamglogene autotemcel (Casgevy®) for the treatment of sickle cell disease (SCD).

The Chief Pharmaceutical Officer (CPO) and the SMC have engaged regularly with the marketing authorisation holder, Vertex Pharmaceuticals, on the SMC’s process for assessing the clinical and cost-effectiveness of exagamglogene autotemcel (Casgevy®) for use in the SCD indication in the NHS in Scotland. The SMC would welcome a submission from Vertex for Casgevy® in the SCD indication at any time.

When leasing agricultural land, the Scottish Government endeavours to use the Farming Opportunities for New Entrants (FONE) Group scoring matrix wherever possible.

The Scottish Government is aware of the concerns of some conservation organisations regarding section 16AA of the Wildlife Management and Muirburn (Scotland) Act 2024, where a grouse shooting licence area is determined solely by the applicant. It is considered that there is the potential for the area to be very tightly defined so that it excludes most of the area where relevant offences might take place.

NatureScot have added a condition to licences so that certain relevant offences committed anywhere on the landholding can be taken into consideration as to whether to revoke or suspend a licence.

We are considering whether any further steps need to be taken to address this issue.

Any company which wants to move freight by rail or water rather than by road and which is proposing to invest in new freight handling facilities in Scotland or re-invest in existing facilities in Scotland may apply for Freight Facilities Grant (FFG).

The amount of FFG that will be offered depends on the value of the environmental benefits of the project and the additional costs of moving freight by rail or water, determined by a financial appraisal of the project comparing the cost of the rail or water operation with the road alternative. Grants are limited to a maximum of 50% of the capital expenditure.

The key requirement for payment of grant is that Scottish Ministers must be satisfied that if the proposed facility is not provided, the freight, which would have used it, will in fact be carried by road. This means that there must be soundly based projections of the type and quantity of goods that would use the proposed facility and evidence that these goods are currently transported by road.

FFG is paid in the clear expectation that the freight facility will secure the removal of lorries from specific routes for a specific number of years. In return for FFG support, grant recipients must give a commitment to use the facility for a certain period and move a specified amount of freight through the facility.

Most facilities needed to handle or carry freight on rail or water are eligible under the criteria for FFG for example piers, rail sidings and handling equipment. Funding is limited to capital expenditure. Design and project management costs associated exclusively with the freight facility are also likely to be eligible.

Since the GB wide scheme was introduced in 1997, it has been reviewed on several occasions. These exercises were led by the Department for Transport on behalf of the UK Government with input from both the Scottish and Welsh Governments as well as stakeholders across the logistics sector. The last review was undertaken in 2018. The application criteria for the scheme remains unchanged since the scheme began.

While the Scottish Government remains committed to its vision for an integrated and community-based hearing service in Scotland, re-phasing of funding has meant that not all the challenges we are facing will be addressed in a single budget and therefore there is no community hearing service in operation at this time.

While our response to the Independent Review of Audiology is implemented, we will continue to work with the NHS, Third Sector and private providers to identify and cost an appropriate model of community care for any future service reform, and ensure that the voices of those with lived experience inform this work.

The Ayrshire Growth Deal has faced significant challenges - including cost inflation, technical complexities and the COVID-19 pandemic - which have adversely affected project timelines and budgets. In addition, development of two key projects resulted in them no longer being deemed commercially viable. These challenges have largely been beyond the control of the Growth Deal,

Despite such challenges, partners across the three Ayrshire local authorities have been progressing substantive development work, including a reassessment of capital projects as part of a wider programme review aimed at accelerating progress.

Scottish Government officials continue to work closely with Deal partners to ensure projects are delivered within the remaining period of the Growth Deal and within budget.

The Scottish and UK Government jointly developed an evidence-led and objective place selection methodology for Investment Zones, adapting the approach taken by the UK Government in England when selecting Investment Zone regions.

As part of the place selection process, financial modelling was undertaken to assess the potential economic benefits of the proposed Investment Zones. This analysis considered a range of factors, including wellbeing economy need, employment growth, and the attraction of inward investment. The modelling also examined the anticipated fiscal impact, including potential revenue generation and cost implications for both governments. The place selection methodology was published on 18 August 2023.

In addition, the Scottish Government regularly engages with regional stakeholders including the North East Regional Economic Partnership to ensure that the Investment Zone continues to align with local economic priorities and maximises benefits for businesses and communities within the region. Further assessment and refinement of the financial modelling will continue as the Investment Zone proposals are developed through the Gateway process, to ensure its long-term success.

Investment Zones in Scotland are being jointly delivered by the Scottish and UK Governments. The Scottish Government engages regularly with the UK Government regarding the proposed Investment Zone for the North East region. Weekly progress meetings are held between officials from both Governments to discuss the development of proposals and implementation of the Investment Zone. Additionally, the Scottish and UK Government jointly participate in scheduled fortnightly meetings with the North East Regional Economic Partnership, and more often where required, to ensure continued collaboration.

The Cass Review only considered services offered by NHS England, and the report’s 32 recommendations are made to NHS England. As such, NHS England holds responsibility for implementing these recommendations.

The Scottish Government did, however, commit to closely consider the Review’s findings in the context of NHS Scotland services. Accordingly, the Chief Medical Officer for Scotland convened a multidisciplinary team to consider the Review’s recommendations and how they might be applicable to Scotland, which published its findings on 5 July 2024. The Scottish Government has accepted this report and its recommendations.

A “Task and Finish” group, supported by the Scottish Government’s Chief Operating Officer’s Directorate, has now been convened to design a sustainable model for young people’s gender identity services, and the work of this group will be shaped by the multidisciplinary team’s recommendations. Additionally, as recommended by the report, NHS Greater Glasgow and Clyde ended self-referrals to the Sandyford Gender Identity Clinic in August 2024, and the health board is taking forward work to move young people’s gender identity services into a paediatric clinical setting.

The Budget includes a new investment of £4.5 million to deliver specialist support for ME/CFS, Long Covid and other similar conditions. We are exploring whether bringing clinical and third sector stakeholders together to seek further consensus and clarity around the status and implementation of the NICE guidelines on ME/CFS would help deliver this specialist support and, if so, consideration will be given to whether Healthcare Improvement Scotland (HIS), or another organisation, is well placed to facilitate this work.